Dr. med. Arne Strauß

 
Staff Status
unigoe
 

1-18 of 18
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 Journal Article | Research Paper | 
    ​ ​The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review​
    Lisney, A. R.; Leitsmann, C.; Strauß, A. ; Meller, B. ; Bucerius, J. A. & Sahlmann, C.-O. ​ (2022) 
    Cancers14(15).​ DOI: https://doi.org/10.3390/cancers14153638 
    Details  DOI 
  • 2022 Journal Article
    ​ ​A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)​
    Grünwald, V.; Hilser, T.; Meiler, J.; Goebell, P. J.; Ivanyi, P.; Strauß, A.   & Hartmann, A. et al.​ (2022) 
    Oncology Research and Treatment45(5) pp. 272​-280​.​ DOI: https://doi.org/10.1159/000522043 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry​
    Strauss, A. ; Schmid, M. ; Rink, M.; Moran, M.; Bernhardt, S.; Hubbe, M. & Bergmann, L. et al.​ (2021) 
    Future Oncology,.​ DOI: https://doi.org/10.2217/fon-2020-1020 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancer​
    Uhlig, A.; Uhlig, J.; Trojan, L. ; Woike, M.; Leitsmann, M. & Strauß, A. ​ (2021) 
    Future Oncology17(1) pp. 45​-56​.​ DOI: https://doi.org/10.2217/fon-2020-0900 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Mesorectal Lymph Node Metastases as Index Lesion in 68Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer​
    Leitsmann, C.; Schmid, M. ; Sahlmann, C.-O. ; Trojan, L.   & Strauss, A. ​ (2021) 
    Frontiers in Surgery8.​ DOI: https://doi.org/10.3389/fsurg.2021.637134 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry​
    Boegemann, M.; Schlack, K.; Rink, M.; Bernhardt, S.; Moran, M.; Hubbe, M. & Bergmann, L. et al.​ (2020) 
    Future Oncology16(35) pp. 2939​-2948​.​ DOI: https://doi.org/10.2217/fon-2020-0548 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Radium-223 zur Therapie des metastasierten kastrationsresistenten Prostatakarzinoms (mCRPC): ​Der androgenrezeptorunabhängige Wirkstoff in der therapeutischen Sequenz​
    König, F. ; Strauß, A. ; Johannsen, M.; Mommsen, C.; Fricke, E.; Klier, J. & Mehl, S. et al.​ (2019) 
    Der Urologe59(1) pp. 53​-64​.​ DOI: https://doi.org/10.1007/s00120-019-01052-4 
    Details  DOI 
  • 2019 Journal Article
    ​ ​A prospective, open label, multicenter, randomized phase II trial: Sequential therapy with bevacizumab, RAd001 (everolimus) and axitinib in metastatic renal cell carcinoma (mRCC) (BERAT study).​
    Grünwald, V.; Bergmann, L.; Goebell, P. J.; Strauss, A. ; Meiler, J.; Hartmann, A. & Bedke, J.​ (2019) 
    Journal of Clinical Oncology37(15_suppl) pp. e16097​-e16097​.​ DOI: https://doi.org/10.1200/JCO.2019.37.15_suppl.e16097 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Surgical approaches for treatment of ureteropelvic junction obstruction – a systematic review and network meta-analysis​
    Uhlig, A.; Uhlig, J.; Trojan, L. ; Hinterthaner, M. ; von Hammerstein-Equord, A. & Strauss, A. ​ (2019) 
    BMC Urology19(1).​ DOI: https://doi.org/10.1186/s12894-019-0544-7 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines​
    Bremmer, F. ; Bohnenberger, H. ; Küffer, S. ; Oellerich, T.; Serve, H.; Urlaub, H.   & Strauß, A.  et al.​ (2019) 
    Disease Markers2019 pp. 1​-14​.​ DOI: https://doi.org/10.1155/2019/8298524 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study​
    Strauss, A. ; Uhlig, J.; Lotz, J. ; Trojan, L.   & Uhlig, A.​ (2019) 
    Medicine98(17) pp. e15346​.​ DOI: https://doi.org/10.1097/MD.0000000000015346 
    Details  DOI  PMID  PMC 
  • 2018 Journal Article
    ​ ​Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis​
    Uhlig, A.; Strauss, A. ; Seif Amir Hosseini, A. ; Lotz, J. ; Trojan, L. ; Schmid, M.   & Uhlig, J.​ (2018) 
    European Urology Focus4(6) pp. 924​-936​.​ DOI: https://doi.org/10.1016/j.euf.2017.08.007 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis​
    Uhlig, J.; Strauss, A. ; Rücker, G.; Hosseini, A. S. A. ; Lotz, J. ; Trojan, L.   & Kim, H. S. et al.​ (2018) 
    European Radiology29(3) pp. 1293​-1307​.​ DOI: https://doi.org/10.1007/s00330-018-5660-3 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review​
    von Hardenberg, J.; Schwartz, M.; Werner, T.; Fuxius, S.; Strauss, A. ; Worst, T. S. & Nuhn, P. et al.​ (2017) 
    Urologia Internationalis99(4) pp. 414​-421​.​ DOI: https://doi.org/10.1159/000477943 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy​
    Uhlig, A.; Hahn, O.; Strauss, A. ; Lotz, J. ; Trojan, L. ; Müller-Wille, R.   & Uhlig, J.​ (2017) 
    CardioVascular and Interventional Radiology41(2) pp. 277​-283​.​ DOI: https://doi.org/10.1007/s00270-017-1816-9 
    Details  DOI 
  • 2012 Journal Article | 
    ​ ​N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinoma​
    Behnes, C. L. ; Hemmerlein, B. ; Strauss, A. ; Radzun, H.-J.   & Bremmer, F. ​ (2012) 
    Diagnostic Pathology7 art. 95​.​ DOI: https://doi.org/10.1186/1746-1596-7-95 
    Details  DOI  WoS 
  • 2009 Journal Article
    ​ ​The Impact of Prostate Volume Changes during External-Beam Irradiation in Consequence of HDR Brachytherapy in Prostate Cancer Treatment​
    Herrmann, M. K. A.; Gsaenger, T.; Strauss, A. ; Kertesz, T.; Wolff, H. A.; Christiansen, H. & Vorwerk, H. et al.​ (2009) 
    Strahlentherapie und Onkologie185(6) pp. 397​-403​.​ DOI: https://doi.org/10.1007/s00066-009-1942-7 
    Details  DOI  PMID  PMC  WoS 
  • 2006 Journal Article
    ​ ​TRIMETHOPRIM-SULPHAMETHOXAZOLE -FIRST-LINE TREATMENT FOR URINARY TRACT INFECTION BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS?​
    Strauß, A. ; Seseke, S. ; Seiler, T.; Seseke, F. & Ringert, R. H.​ (2006) 
    European Urology Supplements5(2) pp. 144​.​ DOI: https://doi.org/10.1016/S1569-9056(06)60494-6 
    Details  DOI 

Publication List

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp36221
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.